NCT01773070 / 2012-003073-26: A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study |
|
|
| Completed | 3 | 478 | NA | ABT-450/ritonavir, ABT-450 also known as paritaprevir, ABT-333, dasabuvir, ABT-267, ombitasvir | AbbVie (prior sponsor, Abbott) | Hepatitis C | 10/16 | 10/16 | | |
